載入...
PD-1/PD-L1 Blockade after Transient Lymphodepletion to Treat Myeloma
Early phase clinical trials targeting the programmed death receptor-1/ligand-1 (PD-1/PD-L1) pathway to overcome tumor-mediated immunosuppression have reported promising results for a variety of cancers. This pathway appears to play an important role in the failure of immune reactivity to malignant p...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3891840/ https://ncbi.nlm.nih.gov/pubmed/23616570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1202005 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|